MORE HEAT ON JARVIK AND PFIZER

In the New York Times today, a roundup of the latest rumblings in Congress and the medical profession over Robert Jarvik's role as spokesperson for Pfizer's Lipitor. I'm pleased to note that the Times has been hitting dehype posts for leads lately.